Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference

Rhea-AI Summary

Kestra Medical Technologies (Nasdaq: KMTS) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 2:20 p.m. PT.

Investors and interested parties can watch a live webcast and access a replay via the Kestra investor relations website.

News Market Reaction – KMTS

-9.93%

17 alerts

-9.93% Session close to close

-3.1% Trough in 1 hr 55 min

$1.18B Market Cap

0.5x Rel. Volume

In the Apr 29 session, KMTS declined 9.93%, reflecting a notable negative market reaction. Argus tracked a trough of -3.1% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -9.9% in the session following this news. A negative reaction despite this routine c...

Analysis

The stock moved -9.9% in the session following this news. A negative reaction despite this routine conference update fits a pattern where shares have sometimes sold off after positive news, including a $24.6M revenue quarter with higher 52.6% gross margin. Investors may be weighing ongoing losses, such as the recent $34.2M quarterly net loss, and the presence of an effective S-3ASR shelf from April 1, 2026, which allows future equity offerings.

Key Figures

Q3 FY2026 revenue: $24.6M Gross margin: 52.6% FY2026 revenue guidance: $93M +5 more

8 metrics

Q3 FY2026 revenue $24.6M Quarter ended January 31, 2026; +63% year over year

Gross margin 52.6% Q3 FY2026, up from 43.4% prior-year period

FY2026 revenue guidance $93M Raised guidance; implies 55% growth vs fiscal 2025

Cash and equivalents $291M As of January 31, 2026 per 10-Q and 8-K

Q3 net loss $34.2M Quarter ended January 31, 2026; losses widened with expansion

Equity offering size 6.9M shares; $149.3M net December 2025 equity offering proceeds noted in 10-Q

ASSURE WCD patients Over 33,000 patients Cumulative use as of January 2026 in S-3ASR prospectus

Last close pre-shelf $19.93 Nasdaq closing price on March 31, 2026 disclosed in S-3ASR

Historical Context

5 past events · Latest: Apr 22 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 22	Conference exhibition	Positive	+2.4%	Showcasing Cardiac Recovery System and ASSURE WCD at Heart Rhythm 2026.
Apr 09	Workplace award	Positive	-1.9%	Recognition as a 2026 USA TODAY Top Workplaces award winner.
Mar 25	Deal award finalist	Positive	-0.6%	Named finalist for 2026 GeekWire Deal of the Year for 2025 IPO.
Mar 17	Earnings results	Positive	-7.4%	Strong Q3 growth, higher gross margin, raised FY26 revenue guidance.
Mar 03	Earnings date set	Neutral	+0.8%	Announcement of Q3 FY2026 earnings release and conference call timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive operational and recognition news has often seen mixed or negative next-day price reactions, including a selloff on strong earnings.

Recent Company History

This announcement continues a series of visibility-building events for Kestra. In March 2026 the company reported Q3 revenue of $24.6M, up 63% year over year, raised FY26 revenue guidance to $93M, and highlighted expanding use of its Cardiac Recovery System. Subsequent news emphasized awards, conference participation, and product showcases, with share price reactions alternating between modest gains and pullbacks despite generally positive business developments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13 at 2:20 p.m. Pacific Time.

Interested parties may access the live webcast and a replay of the presentation by visiting the Kestra investor relations website.

About Kestra Medical Technologies
Kestra Medical Technologies is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com

FAQ

When will Kestra Medical Technologies (KMTS) present at the BofA Securities 2026 Healthcare Conference?

Kestra will present on Wednesday, May 13, 2026 at 2:20 p.m. Pacific Time. According to Kestra Medical Technologies, the session is part of the BofA 2026 Healthcare Conference schedule and is open for webcast viewing and replay on the company website.

How can investors watch the KMTS presentation at the BofA Securities 2026 Healthcare Conference?

Investors can watch a live webcast and replay on the Kestra investor relations website. According to Kestra Medical Technologies, the company will host both the live stream and a later replay for viewers who cannot attend live.

Will Kestra (KMTS) make a replay of its BofA 2026 Healthcare Conference presentation available?

Yes, a replay will be available on the Kestra investor relations website after the live presentation. According to Kestra Medical Technologies, the replay will allow investors to review the presentation at their convenience following the May 13 session.

What time is the Kestra (KMTS) presentation for viewers in Eastern Time?

The presentation is at 5:20 p.m. Eastern Time on May 13, 2026 (2:20 p.m. Pacific Time). According to Kestra Medical Technologies, viewers should convert time zones and can access the live webcast via the company’s investor relations site.

Where can I find more investor information about Kestra Medical Technologies (KMTS) following the conference presentation?

Post-presentation materials and the webcast replay will be available on the Kestra investor relations website. According to Kestra Medical Technologies, the IR site is the primary location for the presentation replay and any related investor materials.